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Monday, March 2, 2009 231aS-transferase-2 is stably associated with them (Clayton et al., 1998). Then an
alternative explanation is that these isoforms also exist in Ctenacroscelis,
and they are alternately arranged and only one of them binds GST-2. The scat-
tering object remains to be identified, but the alternating arrangement of tropo-
myosin isoforms is the most conceivable mechanism to provide the periodicity
needed to create the peculiar meridional reflection.
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Smooth muscle (SM) is unique in its ability to maintain force for long periods
of time at low energy cost. This property is called the latch-state. One of the
assumptions of the latch state model of Hai and Murphy is that myosin must
first be phosphorylated in order to attach to the thin filament. However, we pre-
viously demonstrated that unphosphorylated (unPHOS) myosin can attach to
unregulated actin filaments. The goal of this study was to measure the binding
force of unPHOS SM myosin to tropomyosin-regulated actin filaments. A mi-
crosphere captured in a laser trap was attached to an actin filament decorated
with SM tropomyosin-a and b. The filament was brought in contact with a ped-
estal coated with unPHOS pig antrum myosin. The pedestal was then moved
away from the trap at constant velocity (0.5 mm.s-1). Despite pulling the pedes-
tal away, the microsphere did not move until the force exerted by the trap on the
microsphere was sufficient to overcome the binding force of myosin on the ac-
tin/tropomyosin filament. At this point, the microsphere sprang back to its un-
loaded position. The force of unbinding was calculated as the product of the
trap stiffness and the maximal displacement of the trapped microsphere, as as-
sessed by displacement of its center of mass. The average force of unbinding
per myosin molecule (Funb) was obtained by dividing the measured force of un-
binding by the number of myosin molecules estimated per actin filament length.
We found that Funb was greater in presence (0.222 pN 5 0.018; mean5SE)
than in absence (0.142 pN 5 0.019; p<0.001) of tropomyosin. These results
demonstrate that tropomyosin strengthens the bond between unPHOS myosin
and actin. Future studies will investigate the role of other regulatory proteins
of the thin filament.
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Movement of tropomyosin (Tm) on thin filaments in response to Ca2þ-binding
to troponin and myosin binding to actin is an inherent feature of muscle reg-
ulation. As part of this process, the cable-like mechanical properties of the Tm
coiled-coil are thought to underlie cooperative on and off switching of con-
traction. In principle, movement of Tm over the flat surface of actin may
not require significant molecular flexibility. However, local perturbations
caused, for example, by myosin binding on actin may necessitate some plas-
ticity of the Tm molecule. In contrast, any large-scale Tm flexibility might
dampen its cooperative movement. In the current study, we directly assessed
the flexibility of Tm by examining EM images of both rotary shadowed and
negatively stained molecules. Single Tm molecules in both image sets showed
no obvious signs of sharp bending or kinks, and displayed contours close to
those predicted from a high-resolution 3D model of Tm (Lorenz et al.,
1995). Short multimeric strings of end-to-end bonded Tm were commonly ob-
served in the rotary shadowed images. These showed no pronounced bending
or joints at the intermolecular junctions. The persistence length of Tm was cal-
culated to be over twice the length of the molecule based on these EM images.
The data as a whole imply that Tm molecules exhibit an intrinsic stiffness suf-
ficient to contribute to cooperativity on thin filaments and thus are consistent
with models of muscle regulation (e.g. Lehrer & Geeves, 1998; Lehman et al.,
2000). A tropomyosin mutant in which the coiled-coil interface was destabi-
lized by introduction of Ala clusters in the 2nd and 3rd periodic repeats
(Y60A-L64A-L106A; Singh & Hitchcock-DeGregori, unpublished) was also
examined by EM. No obvious extra bending was observed, although the cal-
culated persistence length was significantly shortened, showing the sensitivity
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Previously, we have discovered small molecules that increase cardiac contrac-
tility by directly activating the cardiac sarcomere; this mechanism is now being
investigated as a therapy for treating systolic heart failure. Using this precedent,
we have focused on the identification of compounds that directly increase
skeletal muscle contractility for the potential therapy of diseases that result
in muscle weakness and fatigue.
CK-1909178 is a member of a class of fast skeletal troponin activators that were
identified by high throughput screening of skeletal sarcomere preparations. We
sought to understand how this compound altered force development in isomet-
ric skinned and live muscle fibers. Treatment of skinned rabbit psoas fibers with
0.1 mM CK-1909178 caused a dose-dependent left-shift of the force-pCa rela-
tionship without altering the Hill slope or maximum force, consistent with a cal-
cium sensitizing effect on force production. In living rat flexor digitorum brevis
(FDB) preparations, CK-1909178 (10 mM) caused significant increases in sub-
tetanic force (150% of control at 10 Hz) without altering maximum force. Sim-
ilar experiments were then performed using a rat extensor digitorum longus
(EDL) preparation in-situ, where nervous and vascular connections were left
intact and the muscle was stimulated via the peroneal nerve. Infusions of
CK-1909178 up to 10 mg/kg rapidly increased sub-tetanic isometric force
(190% of control at 30 Hz). In summary, we have identified a skeletal troponin
activator that sensitizes the sarcomere to calcium and results in increased sub-
maximal muscle force development in-vitro and in-situ. We believe that this
mechanism may translate to improved physical power and strength in diseases
where muscle function is compromised due to injury, disease or age.
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Striated muscle contraction is tightly coupled to the release of Ca2þ from the
sarcoplasmic reticulum by the sarcomeric calcium sensor, troponin. This com-
plex of three proteins (troponins T, I, and C) undergoes calcium-sensitive con-
formational changes that regulate the accessibility of myosin binding sites
along the actin filament. We used a high throughput screen to identify com-
pounds that activate the ATPase activity of skinned fast skeletal myofibrils;
optimization of the initial hit compounds has resulted in compounds with
sub-micromolar affinity. A potent representative of this chemical series, CK-
1909178, shifts the calcium sensitivity of detergent skinned skeletal myofibrils
by >10-fold in a concentration dependent manner. This compound specifically
activates fast skeletal myofibrils, with no effect on either slow skeletal or car-
diac myofibrils. A reconstituted sarcomere assay using combinations of fast
skeletal, slow skeletal, and cardiac components demonstrates that the activity
of CK-1909178 requires the presence of fast skeletal troponin. Isothermal titra-
tion calorimetry indicates the compound binds directly to fast skeletal troponin
with a sub-micromolar dissociation constant. Consistent with its calcium sen-
sitization effects, CK-1909178 slows the dissociation of calcium from troponin
as measured by Quin-2 fluorescence. Consistent with its mechanism of action,
CK-1909178 sensitizes muscle in vitro and in vivo, suggesting this mechanism
may increase power or strength in diseases where muscle function is compro-
mised due to injury, disease or age.
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The binding of Ca2þ to cardiac troponin C (cTnC) triggers contraction in heart
muscle. In diseased heart, the myocardium is often desensitized to Ca2þ, lead-
ing to weak cardiac contractility. Compounds that can sensitize cardiac muscle
to Ca2þ have therapeutic value in treating heart failure. Of the known drugs
that are proposed to accomplish this, levosimendan is the best characterized
and currently in clinical use. Levosimendan interacts with the regulatory do-
main of cTnC and promotes association of cTnC with troponin I (cTnI). De-
tailed understanding of the mechanism of levosimendan has been concealed
by its unstable nature; however, the use of analogues that are more stable would
